174 related articles for article (PubMed ID: 24476798)
1. Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.
Capone S; Naddeo M; D'Alise AM; Abbate A; Grazioli F; Del Gaudio A; Del Sorbo M; Esposito ML; Ammendola V; Perretta G; Taglioni A; Colloca S; Nicosia A; Cortese R; Folgori A
Mol Ther; 2014 May; 22(5):1039-47. PubMed ID: 24476798
[TBL] [Abstract][Full Text] [Related]
2. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
4. Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.
Spencer AJ; Cottingham MG; Jenks JA; Longley RJ; Capone S; Colloca S; Folgori A; Cortese R; Nicosia A; Bregu M; Hill AV
PLoS One; 2014; 9(6):e100538. PubMed ID: 24945248
[TBL] [Abstract][Full Text] [Related]
5. MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans.
Esposito I; Cicconi P; D'Alise AM; Brown A; Esposito M; Swadling L; Holst PJ; Bassi MR; Stornaiuolo M; Mori F; Vassilev V; Li W; Donnison T; Gentile C; Turner B; von Delft A; Del Sorbo M; Barra F; Contino AM; Abbate A; Novellino E; Thomsen AR; Christensen JP; Lahm A; Grazioli F; Ammendola V; Siani L; Colloca S; Klenerman P; Nicosia A; Dorrell L; Folgori A; Capone S; Barnes E;
Sci Transl Med; 2020 Jun; 12(548):. PubMed ID: 32554708
[TBL] [Abstract][Full Text] [Related]
6. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
Swadling L; Capone S; Antrobus RD; Brown A; Richardson R; Newell EW; Halliday J; Kelly C; Bowen D; Fergusson J; Kurioka A; Ammendola V; Del Sorbo M; Grazioli F; Esposito ML; Siani L; Traboni C; Hill A; Colloca S; Davis M; Nicosia A; Cortese R; Folgori A; Klenerman P; Barnes E
Sci Transl Med; 2014 Nov; 6(261):261ra153. PubMed ID: 25378645
[TBL] [Abstract][Full Text] [Related]
7. MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines.
Holst PJ; Sorensen MR; Mandrup Jensen CM; Orskov C; Thomsen AR; Christensen JP
J Immunol; 2008 Mar; 180(5):3339-46. PubMed ID: 18292559
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage.
Jensen S; Steffensen MA; Jensen BA; Schlüter D; Christensen JP; Thomsen AR
J Immunol; 2013 Oct; 191(8):4152-64. PubMed ID: 24043891
[TBL] [Abstract][Full Text] [Related]
9. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
[TBL] [Abstract][Full Text] [Related]
10. Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.
Atcheson E; Li W; Bliss CM; Chinnakannan S; Heim K; Sharpe H; Hutchings C; Dietrich I; Nguyen D; Kapoor A; Jarvis MA; Klenerman P; Barnes E; Simmonds P
Hepatology; 2020 Mar; 71(3):794-807. PubMed ID: 31400152
[TBL] [Abstract][Full Text] [Related]
11. Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
Tan WG; Zubkova I; Kachko A; Wells F; Adler H; Sutter G; Major ME
PLoS One; 2017; 12(7):e0181578. PubMed ID: 28732046
[TBL] [Abstract][Full Text] [Related]
12. Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination.
Vidalin O; Tanaka E; Spengler U; Trépo C; Inchauspé G
DNA Cell Biol; 1999 Aug; 18(8):611-21. PubMed ID: 10463057
[TBL] [Abstract][Full Text] [Related]
13. Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee.
Woollard DJ; Grakoui A; Shoukry NH; Murthy KK; Campbell KJ; Walker CM
Hepatology; 2003 Nov; 38(5):1297-306. PubMed ID: 14578870
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans.
Kelly C; Swadling L; Capone S; Brown A; Richardson R; Halliday J; von Delft A; Oo Y; Mutimer D; Kurioka A; Hartnell F; Collier J; Ammendola V; Del Sorbo M; Grazioli F; Esposito ML; Di Marco S; Siani L; Traboni C; Hill AV; Colloca S; Nicosia A; Cortese R; Folgori A; Klenerman P; Barnes E
Hepatology; 2016 May; 63(5):1455-70. PubMed ID: 26474390
[TBL] [Abstract][Full Text] [Related]
15. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
[TBL] [Abstract][Full Text] [Related]
16. Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting.
Rollier C; Verschoor EJ; Paranhos-Baccala G; Drexhage JA; Verstrepen BE; Berland JL; Himoudi N; Barnfield C; Liljestrom P; Lasarte JJ; Ruiz J; Inchauspe G; Heeney JL
J Infect Dis; 2005 Sep; 192(5):920-9. PubMed ID: 16088843
[TBL] [Abstract][Full Text] [Related]
17. High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome.
Gómez CE; Perdiguero B; Cepeda MV; Mingorance L; García-Arriaza J; Vandermeeren A; Sorzano CÓ; Esteban M
J Virol; 2013 Jul; 87(13):7282-300. PubMed ID: 23596307
[TBL] [Abstract][Full Text] [Related]
18. Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8
Halbroth BR; Sebastian S; Poyntz HC; Bregu M; Cottingham MG; Hill AVS; Spencer AJ
Sci Rep; 2018 Oct; 8(1):15020. PubMed ID: 30301933
[TBL] [Abstract][Full Text] [Related]
19. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression.
Marín MQ; Pérez P; Gómez CE; Sorzano CÓS; Esteban M; García-Arriaza J
Viruses; 2018 Aug; 10(8):. PubMed ID: 30096846
[TBL] [Abstract][Full Text] [Related]
20. Adenoviruses vectored hepatitis C virus vaccine cocktails induce broadly specific immune responses against multi-genotypic HCV in mice.
Luo S; Zhang P; Wang Y; Huang Y; Ma X; Deng Q; Zou P; Wang C; Zhang L; Li Y; Fu Y; Li T; Li C
Biomed Pharmacother; 2024 Jan; 170():115901. PubMed ID: 38056238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
